Capgemini: accelerating the bioeconomy with generative AI
(CercleFinance.com) - Capgemini announces a new protein engineering methodology based on generative AI, reducing data requirements by 99% by identifying the most efficient protein variants.
Currently in the process of being patented, this new approach will significantly reduce the time and resources required for R&D, and will help support key scientific advances in sectors such as healthcare, agriculture and environmental sciences, Capgemini says.
Applications include optimising enzymes for plastic degradation and reducing the number of bioengineering experiments required.
With this approach, Capgemini can help its clients reduce the development costs of biosolutions and create use cases that were previously unviable.
Copyright (c) 2025 CercleFinance.com. All rights reserved.
Currently in the process of being patented, this new approach will significantly reduce the time and resources required for R&D, and will help support key scientific advances in sectors such as healthcare, agriculture and environmental sciences, Capgemini says.
Applications include optimising enzymes for plastic degradation and reducing the number of bioengineering experiments required.
With this approach, Capgemini can help its clients reduce the development costs of biosolutions and create use cases that were previously unviable.
Copyright (c) 2025 CercleFinance.com. All rights reserved.